Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $101.08 USD
Change Today +0.62 / 0.62%
Volume 6.6M
JNJ On Other Exchanges
Symbol
Exchange
New York
Mexico
Sao Paulo
Bogota
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paulus A. Stoffels Ph.D.

Worldwide Chairman of Pharmaceuticals, Chief Scientific Officer and Member of Executive Committee, Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 5 different industries.

See Board Relationships
52$18,339,317
As of Fiscal Year 2014

Background*

Dr. Paul A. Stoffels, Ph.D. serves as Worldwide Chairman of Pharmaceuticals at Janssen Research & Development, LLC since January 3, 2011 and has been its Chief Scientific Officer since October 1, 2012. Since 2009, Dr. Stoffels served as Global Head at Johnson & Johnson Pharmaceutical Research & Development. Dr. Stoffels serves as a Member of Scientific Advisory Board of Index Life VI. Dr. Stoffels Co-founded Tibotec-Virco NV in 2001 and served as its Chairman and Managing ...

Read Full Background

Corporate Headquarters*

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships*

Former Chairman
Co-Founder
Former Director

Education*

MD
University of Antwerp

Other Affiliations*

Annual Compensation*

Salary$1,075,423
Total Annual Compensation$1,075,423

Stock Options*

Restricted Stock Awards$10,690,520
All Other Compensation$425,088
Exercisable Options68,550
Exercisable Options Value$2,936,353
Unexercisable Options543,167
Unexercisable Options Value$16,031,323
Total Value of Options$18,967,675
Total Number of Options611,717

Total Compensation*

Total Annual Cash Compensation$4,073,961
Total Short Term Compensation$1,075,423
Other Long Term Compensation$11,115,608
Total Calculated Compensation$18,339,317
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $101.08 USD +0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brian M. Krzanich Chief Executive Officer, Director and Member of Executive Committee
Intel Corporation
$1.0M
Virginia M. Rometty Chairman, Chief Executive Officer, President and Chairman of Executive Committee
International Business Machines Corporation
$1.5M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$9.2M
Joseph Jimenez MBAChief Executive Officer
Novartis AG
SFr.6.1M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.